Intensive Care Medicine

Section I. Genetic Factors

1. Are Pharmacogenetics and Pharmacogenomics Important for Critically III Patients?
C. Kirwan, I. MacPhee, B. Philips

2. Genetic Susceptibility in ALI/ARDS: What have we Learned?
R. Cartin-Ceba, M. N. Gong, O. Gajic

3. Racial Disparities in Infection and Sepsis: Does Biology Matter?
F. B. Mayr, S. Yende, D. C. Angus

Section II. Cardiac Issues

4. B-Type Natriuretic Peptide: An Emerging Biomarker in Pediatric Critical Care
P. E. Oishi, J. -H. Hsu, J. R. Fineman

5. Cardiac Dysfunction in Septic Shock
I. Cinel, R. Nanda, R. P. Dellinger

6. The Consequences of Cardiac Autonomic Dysfunction in Multiple Organ Dysfunction Syndrome
H. Schmidt, U. Müller-Werdan, K. Werdan

7. Quantification of Improved Left Ventricular Performance during Cardiac Resynchronization Therapy
B. Lamia, M. R. Pinsky

8. Diastolic Dysfunction and Cardiac Failure in the Intensive Care Unit
J. Poelaert, E. Osipowska, C. Verborgh

9. Pharmacological Support of the Failing Right Ventricle
P. F. Wouters, S. Rex, C. Missant

10. Perioperative Cardioprotection
H. -J. Priebe

Section III. Cardiopulmonary Resuscitation

11. Improving the Quality of Cardiac Arrest Resuscitation Care
C. J. Dine, B. S. Abella

12. Pediatric Cardiopulmonary Arrest and Resuscitation
A. Topjian, R. A. Berg, V. M. Nadkarni

13. Early Cooling in Cardiac Arrest: What is the Evidence?
L. Hammer, C. Adrie, J. -F. Timsit

Section IV. Emergencies

14. Management of Severe Accidental Hypothermia
G. J. Peek, P. R. Davis, J. A. Ellerton

15. Initial ICU Management of Skin Sloughing Diseases: Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
T. L. Palmieri

Section V. Poisonings

16. Pathophysiology of Caustic Ingestion
M. Osman, D. N. Granger

17. Extracorporeal Life-Support for Acute Drug-induced Cardiac Toxicity
B. Mégarbane, N. Deye, F. J. Baud

Section VI. Acute Respiratory Failure

18. Epidemiology of Acute Respiratory Failure and Mechanical Ventilation
H. S. Suri, G. Li, O. Gajic

19. Esophagectomy and Acute Lung Injury
D. P. Park, D. Gourevitch, G. D. Perkins

20. Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: Friend or Foe?
P. Pelosi, P. R. M. Rocco

21. Regional Lung Function in Critically III Neonates: A New Perspective for Electrical Impedance Tomography
I. Frerichs, J. Scholz, N. Weiler

22. Extracorporeal Lung Assist for Acute Respiratory Distress Syndrome: Past, Present and Future
R. Kopp, U. Steinseifer, R. Rossaint

Section VII. Ventilatory Support

23. Protective Mechanical Ventilation: Lessons Learned From Alveolar Mechanics
S. Albert, B. Kubiak, G. Nieman

24. Mechanical Ventilation for Acute Asthma Exacerbations
D. Mendoza, M. Lujan, J. Rello

25. Hypercapnia: Permissive, Therapeutic, or Not at All?
P. Hassett, M. Contreras, J. G. Laffey

26. The Cardiopulmonary Effects of Hypercapnia
T. Manca, L. C. Welch, J. I. Sznajder

27. High Frequency Oscillation for Acute Respiratory Failure in Adults
S. D. Mentzelopoulos, C. Roussos, S. G. Zakynthinos

28. Airway Pressure Release Ventilation: Promises and Potentials for Concern
J. Gutiérrez Mejía, E. Fan, N. D. Ferguson

29. Postoperative Non-invasive Ventilation
S. Jaber, G. Chanques, B. Jung

Section VIII. Tracheostomy

30. Choice of Tracheostomy Tube: Does One Size Fit All?
J. Oram, A. Bodenham

31. What’s new in Percutaneous Dilational Tracheostomy?
T. A. Treschan, B. Pannen, M. Beiderlinden

Section IX. Infections

32. Novel Therapies in the Prevention of Ventilator-associated Pneumonia
P. J. Young, M. C. Blunt

33. Management of Ventilator-associated Pneumonia
M. Ferrer, M. Valencia, A. Torres

34. Flucytosine Combined with Amphotericin B for Fungal Infections: A Postmarketing Surveillance and Future Perspectives
P. H. J. Voort

Section X. Cellular Mechanisms in Sepsis

35. Apoptosis in Critical Illness: A Primer for the Intensivist
Z. Malam, J. C. Marshall

36. Regulation of Mitochondrial Function by Hypoxia and Inflammation in Sepsis: A Putative Role for Hypoxia Inducible Factor
T. Regueira, S. M. Jakob, S. Djafarzadeh

37. Gram-positive and Gram-negative Sepsis: Two Disease Entities?
S. Leaver, A. Burke Gaffney, T. W. Evans

38. Methicillin-resistant Staphylococcus aureus-induced Sepsis: Role of Nitric Oxide
P. Enkhbaatar, L. Traber, D. Traber

Section XI. Sepsis Therapies

39. The Cardiovascular Management of Sepsis
B. C. Creagh-Brown, J. Ball, M. Hamilton

40. Terlipressin in Septic Shock: When and How Much?
C. Ertmer, A. Morelli, M. Westphal

41. Blood Purification Techniques in Sepsis and SIRS
P. M. Honoré, O. Joannes-Boyau, B. Gressens

42. Glutathione in Sepsis and Multiple Organ Failure
U. Fläring, J. Wernerman

43. Selenocompounds and Selenium: A Biochemical Approach to Sepsis
X. Forceville, P. Antwerpen

Section XII. Metabolic Alterations

44. The Role of Hypoxia and Inflammation in the Expression and Regulation of Proteins Regulating Iron Metabolism
S. Brandt, J. Takala, P. M. Lepper

45. Hyperammonemia in the Adult Critical Care Setting
K. Dams, W. Meersseman, A. Wilmer

46. Magnesium in the ICU: Sine qua non

F. Esen, L. Telci

47. Strict Glycemic Control: Not If and When, but Who and How?
M. J. Graaff, P. E. Spronk, M. J. Schultz

48. Cortisol Metabolism in Inflammation and Sepsis
B. Venkatesh, J. Cohen

Section XIII. Fluid Management

49. Assessment of Perioperative Fluid Balance
M. T. Ganter, C. K. Hofer

50. Fluid Resuscitation and Intra-abdominal Hypertension
I. E. Laet, J. J. Waele, M. L. N. G. Malbrain

Section XIV. Acute Kidney Injury

51. Six Truths about Acute Kidney Injury that the Intensivist Should Be Aware Of
E. A. J. Hoste

52. Role of Poly(ADP-Ribose) Polymerase in Acute Kidney Injury
R. Vaschetto, F. B. Plötz, A. B. J. Groeneveld

53. From Hemodynamics To Proteomics: Unraveling the Complexity of Acute Kidney Injury in Sepsis
M. Matejovic, P. Radermacher, V. Thongboonkerd

Section XV. Hemodynamic Assessment and Management

54. Towards Optimal Central Venous Catheter Tip Position
W. Schummer, Y. Sakr, C. Schummer

55. From Arterial Pressure to Cardiac Output
M. Cecconi, A. Rhodes, G. Rocca

56. Hemodynamic Monitoring: Requirements of Less Invasive Intensive Care — Quality and Safety
A. Vieillard-Baron

57. Minimally Invasive Cardiac Output Monitoring: Toy Or Tool?
G. Marx, T. Schuerholz

58. Bioreactance: A New Method for Non-invasive Cardiac Output Monitoring
P. Squara

59. Goal-directed Hemodynamic Therapy for Surgical Patients
P. Morgan, A. Rhodes

Section XVI. Tissue Oxygenation

60. Use of Mixed Venous Oxygen Saturation in ICU Patients
M. Leone, V. Blasco, C. Martin

61. Early Optimization of Oxygen Delivery in High-risk Surgical Patients
S. M. Lobo, E. Rezende, F. Suparregui Dias

62. The Influence of Packed Red Blood Cell Transfusion on Tissue Oxygenation
S. Suttner, J. Boldt

63. Recent Advancements in Microcirculatory Image Acquisition and Analysis
R. Bezemer, M. Khalilzada, C. Ince

64. The Beneficial Effects of Increasing Blood Viscosity
B. Y. Salazar Vázquez, P. Cabrales, M. Intaglietta

Section Section XVII. Anticoagulants in Organ Failure

65. Protein C and Antithrombin Levels in Surgical and Septic Patients
Y. Sakr, N. C. M. Youssef, K. Reinhart

66. Thrombophilia as a Risk Factor for Outcome in Sepsis
J. -J. Hofstra, M. Schouten, M. Levi

67. The Effects of Activated Protein C on the Septic Endothelium
S. E. Orfanos, N. A. Maniatis, A. Kotanidou

68. Improvement in Hemodynamics by Activated Protein C in Septic Shock
X. Monnet, H. Ksouri, J. -L. Teboul

Section XVIII. Acute Bleeding

69. Gastrointestinal Hemorrhage on the Intensive Care Unit
S. J. Thomson, M. L. Cowan, T. M. Rahman

70. Recombinant Activated Factor VII: The Delicate Balance between Efficacy and Safety
S. Bélisle, J. -F. Hardy, P. Linden

Section XIX. Hepatic Disease

71. ICU Management of the Liver Transplant Patient
G. Rocca, M. G. Costa, P. Chiarandini

72. Liver Support with Fractionated Plasma Separation and Adsorption and Prometheus®
K. Rifai, C. Tetta, C. Ronco

73. Artificial Liver Support: Current Status
F. Saliba, P. Ichaï, D. Samuel

Section XX. Neurological Crises

74. Encephalopathy in Sepsis
A. Polito, S. Siami, T. Sharshar

75. Multimodality Monitoring in Patients with Elevated Intracranial Pressure
D. B. Seder, J. M. Schmidt, S. A. Mayer

76. Managing Critically III Patients with Status Epilepticus
S. Legriel, J. P. Bedos, E. Azoulay

Section XXI. Analgesia and Sedation

77. Sedation with Inhaled Anesthetics in Intensive Care
F. J. Belda, M. Soro, A. Meiser

78. Sedation or Analgo-sedation in the ICU: A Multimodality Approach
F. Meurant, A. Bodart, J. P. Koch

Section XXII. Outcomes

79. Time to Use Computerized Physician Order Entry in all ICUs?
J. Ali, A. Vuylsteke

80. Quality of Life in Locked-in Syndrome Survivors
M. -A. Bruno, F. Pellas, S. Laureys

81. Post-traumatic Stress Disorder in Intensive Care Unit Survivors
J. Griffiths, A. M. Hull, B. H. Cuthbertson

Nyckelord: Medicine & Public Health, Intensive / Critical Care Medicine, Emergency Medicine, Internal Medicine